5-HT2 Receptor Subfamily and the Halogen Bond Promise
暂无分享,去创建一个
Gerald Zapata-Torres | Angelica Fierro | Bruce K. Cassels | Douglas J. Matthies | Pablo Jaque | P. Jaque | A. Fierro | B. Cassels | G. Zapata-Torres
[1] S. Iwata,et al. Structures of the 5-HT2A receptor in complex with the antipsychotics risperidone and zotepine , 2019, Nature Structural & Molecular Biology.
[2] Pierangelo Metrangolo,et al. The Halogen Bond , 2016, Chemical reviews.
[3] J. Murray,et al. The use and misuse of van der Waals radii , 2021, Structural Chemistry.
[4] Orion B. Berryman,et al. Hydrogen Bond Enhanced Halogen Bonds: A Synergistic Interaction in Chemistry and Biochemistry. , 2019, Accounts of chemical research.
[5] J. González-Maeso,et al. Psychedelic-like Properties of Quipazine and Its Structural Analogues in Mice. , 2021, ACS chemical neuroscience.
[6] Peter Politzer,et al. Halogen bonding: an interim discussion. , 2013, Chemphyschem : a European journal of chemical physics and physical chemistry.
[7] J. Murray,et al. Electrostatics and Polarization in σ- and π-Hole Noncovalent Interactions: An Overview. , 2019, Chemphyschem : a European journal of chemical physics and physical chemistry.
[8] R. Glennon,et al. Serotonin receptor binding affinities of several hallucinogenic phenylalkylamine and N,N-dimethyltryptamine analogues. , 1978, Journal of medicinal chemistry.
[9] Pierangelo Metrangolo,et al. Halogen bonding in halocarbon-protein complexes: a structural survey. , 2011, Chemical Society reviews.
[10] P A Kollman,et al. Photoelectron spectra of psychotropic drugs. 6. Relationships between the physical properties and pharmacological actions of amphetamine analogues. , 1981, Journal of medicinal chemistry.
[11] K. Miller,et al. Discovery and development of 5-HT(₂C) receptor agonists for obesity: is there light at the end of the tunnel? , 2010, Future medicinal chemistry.
[12] D. C. Dyer,et al. Psychotomimetic phenylisopropylamines. 5. 4-Alkyl-2,5-dimethoxyphenylisopropylamines. , 1975, Journal of medicinal chemistry.
[13] Pierangelo Metrangolo,et al. The Halogen Bond in the Design of Functional Supramolecular Materials: Recent Advances , 2013, Accounts of chemical research.
[14] Rafał Kurczab,et al. The Significance of Halogen Bonding in Ligand–Receptor Interactions: The Lesson Learned from Molecular Dynamic Simulations of the D4 Receptor , 2019, Molecules.
[15] David E. Gloriam,et al. 5-HT2C Receptor Structures Reveal the Structural Basis of GPCR Polypharmacology , 2018, Cell.
[16] Xi-Ping Huang,et al. Exploring Halogen Bonds in 5-Hydroxytryptamine 2B Receptor-Ligand Interactions. , 2018, ACS medicinal chemistry letters.
[17] Peter Politzer,et al. An overview of halogen bonding , 2007, Journal of molecular modeling.
[18] Michael R. Braden,et al. Assessment of the Roles of Serines 5.43(239) and 5.46(242) for Binding and Potency of Agonist Ligands at the Human Serotonin 5-HT2A Receptor , 2007, Molecular Pharmacology.
[19] Satoru Suzuki,et al. Probing the effect of the binding site on the electrostatic behavior of a series of carotenoids reconstituted into the light-harvesting 1 complex from purple photosynthetic bacterium Rhodospirillum rubrum detected by stark spectroscopy. , 2008, The journal of physical chemistry. B.
[20] S. Snyder,et al. 2,5-Dimethoxy-4-methyl-amphetamine (STP): A New Hallucinogenic Drug , 1967, Science.
[21] I. Kusumi,et al. Psychopharmacology of atypical antipsychotic drugs: From the receptor binding profile to neuroprotection and neurogenesis , 2015, Psychiatry and clinical neurosciences.
[22] D. E. Nichols,et al. Structure of a Hallucinogen-Activated Gq-Coupled 5-HT2A Serotonin Receptor , 2020, Cell.
[23] A. A. Jensen,et al. Investigation of the 2,5-dimethoxy motif in phenethylamine Serotonin 2A receptor agonists. , 2020, ACS chemical neuroscience.
[24] D E Nichols,et al. Lipophilicity and serotonin agonist activity in a series of 4-substituted mescaline analogues. , 1977, Journal of medicinal chemistry.
[25] Taehoon Kim,et al. CHARMM‐GUI: A web‐based graphical user interface for CHARMM , 2008, J. Comput. Chem..
[26] Matthew W. Johnson,et al. Potential Therapeutic Effects of Psilocybin , 2017, Neurotherapeutics.
[27] B. Roth,et al. A structure-affinity study of the binding of 4-substituted analogues of 1-(2,5-dimethoxyphenyl)-2-aminopropane at 5-HT2 serotonin receptors. , 1990, Journal of medicinal chemistry.
[28] Frederick S. Barrett,et al. Classic psychedelics: An integrative review of epidemiology, therapeutics, mystical experience, and brain network function , 2019, Pharmacology & therapeutics.
[29] Barfknecht Cf,et al. Correlation of psychotomimetic activity of phenethylamines and amphetamines with 1-octanol-water partition coefficients. , 1975 .
[30] M. Narayan,et al. Looking Back, Looking Forward at Halogen Bonding in Drug Discovery , 2017, Molecules.
[31] Gerald Zapata-Torres,et al. Molecular dynamics simulation of halogen bonding mimics experimental data for cathepsin L inhibition , 2014, Journal of Computer-Aided Molecular Design.
[32] B W Clare,et al. Structure-activity correlations for psychotomimetics. 1. Phenylalkylamines: electronic, volume, and hydrophobicity parameters. , 1990, Journal of medicinal chemistry.
[33] R. Stevens,et al. Structural insights into the extracellular recognition of the human serotonin 2B receptor by an antibody , 2017, Proceedings of the National Academy of Sciences.
[34] G. Kennett,et al. Pharmacological characterisation of the agonist radioligand binding site of 5-HT2A, 5-HT2B and 5-HT2C receptors , 2004, Naunyn-Schmiedeberg's Archives of Pharmacology.
[35] Davide Provasi,et al. Decoding the Signaling of a GPCR Heteromeric Complex Reveals a Unifying Mechanism of Action of Antipsychotic Drugs , 2011, Cell.
[36] D E Nichols,et al. Directional lipophilic character in a series of psychotomimetic phenethylamine derivatives. , 1977, Life sciences.
[37] A. Shulgin,et al. 4-Bromo-2,5-dimethoxyphenylisopropylamine, a new centrally active amphetamine analog. , 1971, Pharmacology.
[38] A. Shulgin,et al. Structure–Activity Relationships of One-Ring Psychotomimetics , 1969, Nature.
[39] S. F. Boys,et al. The calculation of small molecular interactions by the differences of separate total energies. Some procedures with reduced errors , 1970 .
[40] David S. Goodsell,et al. AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility , 2009, J. Comput. Chem..
[41] Timothy Clark,et al. Polarization-induced σ-holes and hydrogen bonding , 2012, Journal of Molecular Modeling.
[42] Nicolas K. Shinada,et al. Halogens in Protein-Ligand Binding Mechanism: A Structural Perspective. , 2019, Journal of medicinal chemistry.
[43] A. Joerger,et al. Principles and applications of halogen bonding in medicinal chemistry and chemical biology. , 2013, Journal of medicinal chemistry.
[44] Suman Sirimulla,et al. AutoDock VinaXB: implementation of XBSF, new empirical halogen bond scoring function, into AutoDock Vina , 2016, Journal of Cheminformatics.
[45] Robin Taylor,et al. Intermolecular Nonbonded Contact Distances in Organic Crystal Structures: Comparison with Distances Expected from van der Waals Radii , 1996 .
[46] Piotr Cieplak,et al. The R.E.D. tools: advances in RESP and ESP charge derivation and force field library building. , 2010, Physical chemistry chemical physics : PCCP.
[47] Peter Politzer,et al. Directional tendencies of halogen and hydrogen bonds , 2010 .
[48] W. L. Jorgensen,et al. Comparison of simple potential functions for simulating liquid water , 1983 .
[49] Weiliang Zhu,et al. Halogen Bond: Its Role beyond Drug-Target Binding Affinity for Drug Discovery and Development , 2014, J. Chem. Inf. Model..
[50] C. Barfknecht,et al. Potential psychotomimetics. Bromomethoxyamphetamines. , 1971, Journal of Medicinal Chemistry.
[51] Santiago Alvarez,et al. A cartography of the van der Waals territories. , 2013, Dalton transactions.
[52] Mahmoud A. A. Ibrahim,et al. Molecular mechanical study of halogen bonding in drug discovery , 2011, J. Comput. Chem..
[53] Duncan Poole,et al. Routine Microsecond Molecular Dynamics Simulations with AMBER on GPUs. 1. Generalized Born , 2012, Journal of chemical theory and computation.
[54] Hyeon Joo,et al. OPM database and PPM web server: resources for positioning of proteins in membranes , 2011, Nucleic Acids Res..
[55] Torsten Schwede,et al. SWISS-MODEL: homology modelling of protein structures and complexes , 2018, Nucleic Acids Res..
[56] Pierangelo Metrangolo,et al. Halogen bonding based recognition processes: a world parallel to hydrogen bonding. , 2005, Accounts of chemical research.
[57] David S. Goodsell,et al. RCSB Protein Data Bank: powerful new tools for exploring 3D structures of biological macromolecules for basic and applied research and education in fundamental biology, biomedicine, biotechnology, bioengineering and energy sciences , 2020, Nucleic Acids Res..
[58] D. E. Nichols,et al. Crystal Structure of an LSD-Bound Human Serotonin Receptor , 2017, Cell.
[59] P Voth Regier Andrea and Ho Shing,et al. The role of halogen bonding in inhibitor recognition and binding by protein kinases. , 2007 .
[60] David E. Gloriam,et al. Comprehensive repertoire and phylogenetic analysis of the G protein-coupled receptors in human and mouse. , 2006, Genomics.
[61] D. E. Nichols,et al. Chemistry and Structure-Activity Relationships of Psychedelics. , 2018, Current topics in behavioral neurosciences.
[62] Timothy Clark,et al. Halogen bonding: the σ-hole , 2007 .